- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/10 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 407/10
Total number of patents in this class: 257
10-year publication summary
|
12
|
19
|
13
|
20
|
22
|
16
|
12
|
23
|
12
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Idemitsu Kosan Co., Ltd. | 4219 |
21 |
| LG Chem, Ltd. | 17840 |
19 |
| Merck Patent GmbH | 5663 |
13 |
| The Regents of the University of California | 20556 |
6 |
| Novartis AG | 10345 |
5 |
| Syngenta Participations AG | 1587 |
5 |
| Samsung SDI Co., Ltd. | 9902 |
5 |
| Takeda Pharmaceutical Company Limited | 2721 |
5 |
| Syngenta Limited | 436 |
4 |
| Amyris, Inc. | 365 |
4 |
| Omeros Corporation | 304 |
4 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
4 |
| SFC Co., Ltd. | 333 |
4 |
| Biosplice Therapeutics, Inc. | 160 |
4 |
| F. Hoffmann-La Roche AG | 7839 |
3 |
| Samsung Display Co., Ltd. | 37933 |
3 |
| Boehringer Ingelheim International GmbH | 4510 |
3 |
| Heliatek GmbH | 135 |
3 |
| Beijing Increase Innovative Drug Co., Ltd | 9 |
3 |
| Samsung Electronics Co., Ltd. | 154120 |
2 |
| Other owners | 137 |